Content about Epistaxis

June 21, 2012

Biolife in May launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. While hemostat products have been introduced into the first aid set before, this is the first one targeting patients on a specific therapy.


SUPPLIER NEWS — Biolife in May launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. While hemostat products have been introduced into the first aid set before, this is the first one targeting patients on a specific therapy.


June 1, 2012

Biolife last month launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners.

SARASOTA, Fla. — Biolife last month launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. The first aid powder instantly helps to stop bleeding, Biolife noted.

According to the company, as many as 52 million Americans are taking blood thinners and 11% stop taking those medicines because of "nuisance bleeding."